Pentaomix is a health care startup that is devoted to "Shedding Light on Cancer" through the use of hyper-spectral imaging and AI-driven technologies. Established in 2018, Pentaomix aims to revolutionize cancer diagnostics with their pioneering approach. Their innovative solution has garnered attention for its potential to significantly impact the field of cancer treatment. With a focus on leveraging cutting-edge technology for the betterment of healthcare, Pentaomix stands at the forefront of the fight against cancer. Despite not having publicly disclosed their headquarter location or recent investment details, the potential of Pentaomix in the healthcare industry is definitely worth keeping an eye on for Venture capital firms looking to support groundbreaking developments in the field.
There is no investment information
No recent news or press coverage available for Pentaomix.